HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

S Akinaga Selected Research

monorden (radicicol)

12/2001A radicicol derivative, KF58333, inhibits expression of hypoxia-inducible factor-1alpha and vascular endothelial growth factor, angiogenesis and growth of human breast cancer xenografts.
12/2001Stereospecific antitumor activity of radicicol oxime derivatives.
7/2001Destabilization of steroid receptors by heat shock protein 90-binding drugs: a ligand-independent approach to hormonal therapy of breast cancer.
9/2000Novel oxime derivatives of radicicol induce erythroid differentiation associated with preferential G(1) phase accumulation against chronic myelogenous leukemia cells through destabilization of Bcr-Abl with Hsp90 complex.
8/2000Induction of a heat shock factor 1-dependent stress response alters the cytotoxic activity of hsp90-binding agents.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


S Akinaga Research Topics

Disease

11Neoplasms (Cancer)
01/2016 - 02/2000
5Breast Neoplasms (Breast Cancer)
12/2001 - 03/2000
3Multiple Myeloma
10/2017 - 04/2012
2Leukopenia
10/2015 - 06/2013
2Anemia
10/2015 - 06/2013
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2015 - 11/2013
2Neutropenia
10/2015 - 06/2013
2Body Weight (Weight, Body)
04/2012 - 06/2000
1Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2016
1Toxic Optic Neuropathy
01/2016
1Febrile Neutropenia
10/2015
1Nausea
11/2013
1Exanthema (Rash)
11/2013
1Fatigue
06/2013
1Anorexia
06/2013
1Hypoxia (Hypoxemia)
12/2001
1Pancreatic Neoplasms (Pancreatic Cancer)
05/2001
1Carcinoma (Carcinomatosis)
10/2000
1BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
09/2000
1Lung Neoplasms (Lung Cancer)
06/2000
1Thrombocytopenia (Thrombopenia)
06/2000
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
03/2000

Drug/Important Bio-Agent (IBA)

5monorden (radicicol)IBA
12/2001 - 08/2000
4Proteins (Proteins, Gene)FDA Link
12/2001 - 03/2000
3KW-2478IBA
10/2017 - 04/2012
3ARQ 197IBA
10/2015 - 06/2013
3Pharmaceutical PreparationsIBA
12/2001 - 02/2000
3geldanamycinIBA
12/2001 - 08/2000
37-hydroxystaurosporine (UCN 01)IBA
05/2001 - 02/2000
2Bortezomib (Velcade)FDA Link
10/2017 - 04/2012
2ErbB Receptors (EGF Receptor)IBA
10/2015 - 11/2013
2Erlotinib Hydrochloride (CP 358,774)FDA Link
10/2015 - 11/2013
2Tyrosine Kinase InhibitorsIBA
10/2015 - 11/2013
2Cytochrome P-450 CYP2C19IBA
11/2013 - 06/2013
2Heat-Shock Proteins (Heat-Shock Protein)IBA
04/2012 - 07/2001
2OximesIBA
12/2001 - 09/2000
2KF58333IBA
12/2001 - 12/2001
2Protein Kinase InhibitorsIBA
03/2000 - 02/2000
1Retinaldehyde (Retinal)IBA
01/2016
1Adenosine Triphosphate (ATP)IBA
11/2013
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
12/2001
1Biological ProductsIBA
12/2001
1NucleotidesIBA
12/2001
1tanespimycin (17AAG)IBA
07/2001
1Estrogens (Estrogen)FDA Link
07/2001
1Hormone AntagonistsIBA
07/2001
1Hormones (Hormone)IBA
07/2001
1LigandsIBA
07/2001
1Estrogen ReceptorsIBA
07/2001
1Progesterone Receptors (Progesterone Receptor)IBA
07/2001
1Steroid Receptors (Steroid Receptor)IBA
07/2001
1SteroidsIBA
07/2001
1Molecular Chaperones (Chaperone, Molecular)IBA
07/2001
1Antineoplastic Agents (Antineoplastics)IBA
05/2001
1Dihydrotachysterol (AT 10)IBA
05/2001
1Codon (Codons)IBA
10/2000
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
09/2000
1Phosphotransferases (Kinase)IBA
08/2000
1Transcription Factors (Transcription Factor)IBA
08/2000
1Anti-Bacterial Agents (Antibiotics)IBA
08/2000
1AntigensIBA
07/2000
1GD3 ganglioside (GD(3))IBA
07/2000
1GangliosidesIBA
07/2000
1KF41399IBA
06/2000
1carbazoleIBA
06/2000
1NimustineIBA
06/2000
1LC 6IBA
06/2000
1Cyclin-Dependent Kinases (cdk Proteins)IBA
03/2000
1DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA
03/2000
1Mitomycin (Mitomycin-C)FDA LinkGeneric
03/2000
1Protein Kinase CIBA
02/2000
1CEP 751IBA
02/2000
1DNA (Deoxyribonucleic Acid)IBA
02/2000
1rebeccamycinIBA
02/2000
1midostaurinIBA
02/2000
1NB 506IBA
02/2000

Therapy/Procedure

2Therapeutics
04/2012 - 07/2001
2Drug Therapy (Chemotherapy)
06/2000 - 03/2000
1Intravenous Injections
12/2001
1Oral Administration
06/2000